Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Double

Showing results (51-60 of 94) with videos related to

Pageof 10
Sort By:
Pharmaceutical Research|July 1, 1995
Distribution, metabolism and tumoricidal activity of doxorubicin administered in sorbitan monostearate (Span 60) niosomes in the mouseI F Uchegbu, J A Double, J A Turton, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Potentiation of EO9 anti-tumour activity by hydralazineM C Bibby, N R Sleigh, P M Loadman, et al.
International Journal of Cell Cloning|March 1, 1991
The relationship between the in vitro chemosensitivity of tumor cells and tumor response in vivo in an experimental tumor modelR M Phillips, M C Bibby, J A Double, et al.
British Journal of Cancer|September 25, 1999
Cellular uptake, cytotoxicity and DNA-binding studies of the novel imidazoacridinone antineoplastic agent C1311A M Burger, T C Jenkins, J A Double, et al.
Journal of the National Cancer Institute|February 1, 1989
Reduction of tumor blood flow by flavone acetic acid: a possible component of therapyM C Bibby, J A Double, P M Loadman, et al.
Breast Cancer Research and Treatment|May 1, 1997
Establishment and characterisation of new cell lines from human breast tumours initially established as tumour xenografts in NMRI nude miceR J Hambly, J A Double, M J Thompson, et al.
Investigational New Drugs|August 1, 1992
Pharmacokinetics and cytotoxicity of B.3839, a molecular combination of 5-fluorouracil and N-(2-chloroethyl)-N-nitrosourea, in a mouse modelP M Loadman, M C Bibby, J A Double, et al.
Biochemical Pharmacology|November 16, 2001
Genotyping of NAD(P)H:quinone oxidoreductase (NQO1) in a panel of human tumor xenografts: relationship between genotype status, NQO1 activity and the response of xenografts to Mitomycin C chemotherapy in vivo(1)R M Phillips, A M Burger, H H Fiebig, et al.
Biopharmaceutics & Drug Disposition|November 1, 1994
Drug distribution and a pulmonary adverse effect of intraperitoneally administered doxorubicin niosomes in the mouseI F Uchegbu, J A Turton, J A Double, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1988
Effects of routes of administration of TCNU on its plasma, tissue and tumour concentrationsJ A Double, M C Bibby, P M Loadman, et al.
Pageof 10

Showing results (51-60 of 94) with videos related to

Sort By:
Pageof 10
Pharmaceutical Research|July 1, 1995
Distribution, metabolism and tumoricidal activity of doxorubicin administered in sorbitan monostearate (Span 60) niosomes in the mouseI F Uchegbu, J A Double, J A Turton, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Potentiation of EO9 anti-tumour activity by hydralazineM C Bibby, N R Sleigh, P M Loadman, et al.
International Journal of Cell Cloning|March 1, 1991
The relationship between the in vitro chemosensitivity of tumor cells and tumor response in vivo in an experimental tumor modelR M Phillips, M C Bibby, J A Double, et al.
British Journal of Cancer|September 25, 1999
Cellular uptake, cytotoxicity and DNA-binding studies of the novel imidazoacridinone antineoplastic agent C1311A M Burger, T C Jenkins, J A Double, et al.
Journal of the National Cancer Institute|February 1, 1989
Reduction of tumor blood flow by flavone acetic acid: a possible component of therapyM C Bibby, J A Double, P M Loadman, et al.
Breast Cancer Research and Treatment|May 1, 1997
Establishment and characterisation of new cell lines from human breast tumours initially established as tumour xenografts in NMRI nude miceR J Hambly, J A Double, M J Thompson, et al.
Investigational New Drugs|August 1, 1992
Pharmacokinetics and cytotoxicity of B.3839, a molecular combination of 5-fluorouracil and N-(2-chloroethyl)-N-nitrosourea, in a mouse modelP M Loadman, M C Bibby, J A Double, et al.
Biochemical Pharmacology|November 16, 2001
Genotyping of NAD(P)H:quinone oxidoreductase (NQO1) in a panel of human tumor xenografts: relationship between genotype status, NQO1 activity and the response of xenografts to Mitomycin C chemotherapy in vivo(1)R M Phillips, A M Burger, H H Fiebig, et al.
Biopharmaceutics & Drug Disposition|November 1, 1994
Drug distribution and a pulmonary adverse effect of intraperitoneally administered doxorubicin niosomes in the mouseI F Uchegbu, J A Turton, J A Double, et al.
European Journal of Cancer & Clinical Oncology|August 1, 1988
Effects of routes of administration of TCNU on its plasma, tissue and tumour concentrationsJ A Double, M C Bibby, P M Loadman, et al.
Pageof 10